The Canadian government currently has a limit on the different forms of cannabis available to medical marijuana patients. Cannabis can be purchased in the cured, dry bud form or a THC infused cooking oil, like sunflower oil. These products are lab tested and are shipped in the mail directly to the patients.
From the court hearing of R. v. Smith in 2015, the Supreme Court ruled that restricting patient to dried cannabis only was unconstitutional. Slowly over time licensed producers were allowed to manufacture infused cooking oils for sale. This is a step in the right direction, but doesn’t include all of the options for ways to ingest cannabis. Still concentrates, (shatter, wax, budder) topicals, and capsules are unavailable through Licensed Producers along with infused edibles and beverages. From the R. v. Smith hearing, it allowed patients access to cannabis in all of its forms, but didn’t provide a legal source.
This is where the “grey area” of medical marijuana comes into play. Sick patients need access to medical marijuana is specific forms that they can’t purchase from Licensed Producers. Dispensaries have opened up to provide cannabis in all of its forms to patients. These dispensaries set their own rules and decide whom they allow to make purchases.
The Canadian government changed the medical marijuana system following a court hearing in 2016. The hearing found that it was unconstitutional to not allow patients the option to grow cannabis at home. Patients that are now registered under the ACMPR can have the right to grow cannabis at home for their consumption. Some Licensed Producers sell seeds and/or clones to assist in growing at home. Other than that, Licensed Producers can still only retail dried buds and infused cooking oils.